TELA
TELA Bio, Inc.
TELA Bio, Inc. insider trading
TELA Bio, Inc. is on this site because an insider bought its stock on the open market in the last 30 days. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.
From SEC filings · last 30 days
Recent TELA insider transactions
The filing store could not be read just now — this page tries again on its next refresh. The filings themselves are on SEC EDGAR.
SEC Form 4 data, Q3 2024 to Q2 2026
TELA insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 6 insiders traded TELA on the open market: 5 purchases worth $4.4M and 2 sales worth $230.3K. In the last four quarters alone: 1 purchase ($4M) and 0 sales, by one insider.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | — | — | |
| Q1 2026 | — | — | |
| Q4 2025 | +$4M1 buy | — | |
| Q3 2025 | — | — | |
| Q2 2025 | — | — | |
| Q1 2025 | — | — | |
| Q4 2024 | +$410K4 buys | — | |
| Q3 2024 | — | −$230.3K2 sales |
- Largest purchase
- +$4M of TELA by EW Healthcare Partners Fund 2-UGP, LLC (10% Owner) on Nov 17, 2025.
- Largest sale
- −$166.2K of TELA by Orbimed Advisors LLC (10% Owner) on Jul 02, 2024.
Open-market transactions through Jun 30, 2026most recent first
EW Healthcare Partners Fund 2-UGP, LLC
10% Owner
+$4M
Nov 17, 2025
3,604,000 sh · $1.11
Koblish Antony
Chief Executive Officer · Director
+$200K
Oct 24, 2024
88,888 sh · $2.25
Cuca Roberto
COO and CFO
+$145K
Oct 24, 2024
64,444 sh · $2.25
Talmo Paul
Chief Technology Officer
+$50K
Oct 24, 2024
22,222 sh · $2.25
Firestone Gregory A.
Chief Commercial Officer
+$15K
Oct 24, 2024
6,666 sh · $2.25
Orbimed Advisors LLC
10% Owner
−$166.2K
Jul 02, 2024
36,600 sh · $4.54
Orbimed Advisors LLC
10% Owner
−$64.1K
Jul 01, 2024
13,700 sh · $4.68
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Nov 17, 2025 | EW Healthcare Partners Fund 2-UGP, LLC10% Owner | 3,604,000 | $1.11 | +$4M |
| Oct 24, 2024 | Koblish AntonyChief Executive Officer · Director | 88,888 | $2.25 | +$200K |
| Oct 24, 2024 | Cuca RobertoCOO and CFO | 64,444 | $2.25 | +$145K |
| Oct 24, 2024 | Talmo PaulChief Technology Officer | 22,222 | $2.25 | +$50K |
| Oct 24, 2024 | Firestone Gregory A.Chief Commercial Officer | 6,666 | $2.25 | +$15K |
| Jul 02, 2024 | Orbimed Advisors LLC10% Owner | 36,600 | $4.54 | −$166.2K |
| Jul 01, 2024 | Orbimed Advisors LLC10% Owner | 13,700 | $4.68 | −$64.1K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Don't check TELA — let it ping you
Watch every insider filing the minute it clears the SEC
The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.
TELA Bio, Inc. is outside the 777 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.
Other companies insiders are buying now
Questions
- How much TELA stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 6 TELA Bio, Inc. insiders made 5 open-market purchases worth $4.4M and 2 sales worth $230.3K. In the four quarters to Jun 30, 2026: 1 purchase ($4M) and no sales. The largest purchase was EW Healthcare Partners Fund 2-UGP, LLC buying $4M on Nov 17, 2025. The largest sale was Orbimed Advisors LLC selling $166.2K on Jul 02, 2024.
- Where does TELA insider trading data come from?
- From the Form 4 filings TELA Bio, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.